Fresenius blood-loss drug gets FDA nod

12/27/2007 | Forbes

The FDA on Thursday approved Frankfurt, Germany-based Fresenius SE's blood-thickening solution Voluven for use in patients who have lost massive amounts of blood. Voluven, which has been found to be as safe as similar solutions, including B. Braun Medical's Hespan, works by increasing the volume of red blood cells and plasma.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC